Abstract

DOCKING STUDIES OF NOVEL 1, 2, 4- TRIAZOLE CONTAINING 1HINDOLE- 2, 3-DIONE ANALOGUES AS ANTICANCER PROPERTIES

C. A. Suresh Kumar*, M. Sundarapandian and S. Venkataraman

ABSTRACT

Cancer is a disease characterized by uncontrollable, irreversible, independent, autonomous, uncoordinated and relatively unlimited and abnormal over growth of tissues. 1H-Indole-2, 3-Dioneis an important class of heterocyclic compound which possess interesting biological activities like anti-cancer, anti-microbial, anti-fungal, anti-tubercular, anti-malarial, anti-convulsant, anthelmintic, anti-viral, analgesic and anti-inflammatory activity. The drugs containing triazole groups were the first effective chemotherapeutic agents which were systematically proved for the prevention and cure of bacterial infection in human beings. For the treatment of cancer, Indoleamine 2, 3-dioxygenase (IDO) is emerging as an important new therapeutic drug target characterized by pathological immune suppression. Recent understanding of the molecular pathophysiology of cancer have highlighted that many tyrosine kinases are found upstream or downstream of epidemiologically relevant oncogenes or tumor suppressor, in particular the receptor tyrosine kinases. The present research study is focused on the design of 1H-Indole-2, 3-Dione analogues containing triazole, docking against the known anticancer targets like indoleamine 2, 3-dioxygenase (IDO) and EGFR tyrosine kinase. Twenty Five compounds of 1H-Indole-2, 3-Dione analogues were designed and docked against indoleamine 2, 3-dioxygenase (IDO) and EGFR tyrosine kinase using Auto dock (version 4.2). Among the docked compounds five compounds (Tri1, Tri6, Tri12, Tri16, and Tri20) were showed a significant docking score against target enzyme compared to the standard. The present study concluded that 1H-Indole-2, 3-Dione analogues will be a significant lead for further investigation of anti-cancer properties.

Keywords: 1H-Indole-2, 3-Dione, 1, 2, 4-Triazole, indoleamine 2, 3-dioxygenase, EGFR tyrosine kinase, Anti-cancer properties.